Clinical Trials Logo

Clinical Trial Summary

Detect the PHOX2B Mutation-confirmed congenital central hypoventilation syndrome


Clinical Trial Description

Background: Congenital central hypoventilation syndrome (CCHS) is characterized by compromised chemo-reflexes that results in hypoventilation during sleep. Recently, a heterozygous PHOX2B gene mutation was identified in CCHS. This report was made to increase physicians' awareness of this rare disease.

Methods: A Chinese family of CCHS with presentations from newborn to adulthood and genetic analysis confirming the PHOX2B mutation was analyzed. After identifying central hypoventilation in an adult male (index case), clinical evaluation was performed on the complete family, which consisted of the parents, five siblings, and five offsprings. In addition, pulmonary function test, overnight polysomnography, arterial blood gas, and hypercapnia ventilatory response, and genetic screening for PHOX2B gene mutations were performed on living family members. ;


Study Design

Observational Model: Family-Based, Time Perspective: Cross-Sectional


Related Conditions & MeSH terms


NCT number NCT00652964
Study type Observational
Source National Taiwan University Hospital
Contact Peilin Lee, M.D.
Phone +886-2-23562905
Email leepeilin@ntu.edu.tw
Status Recruiting
Phase N/A
Start date September 2009
Completion date December 2012